# Calciphylaxis epidemiology, risk factors, treatment and survival among French chronic kidney disease patients: a case-control study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/calciphylaxis-epidemiology-risk-factors-treatment-and-survival-among-french/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Raphaël Gaisne,Morgane Péré,V. Menoyo,Maryvonne Hourmant,David Larmet-Burgeot |
| Citations | 51 |
| DOI | 10.1186/s12882-020-01722-y |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://bmcnephrol.biomedcentral.com/track/pdf/10.1186/s12882-020-01722-y |
| OpenAlex ID | https://openalex.org/W3011873295 |
| PMID | 32101140 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Morgane Péré](https://scholariq.org/researchers/morgane-pere/)

## Paper journal

- [BMC Nephrology](https://scholariq.org/journals/bmc-nephrology/)

## Paper primary topic

- [Parathyroid Disorders and Treatments](https://scholariq.org/topics/parathyroid-disorders-and-treatments/)

## Paper topics

- [Parathyroid Disorders and Treatments](https://scholariq.org/topics/parathyroid-disorders-and-treatments/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Peripheral Artery Disease Management](https://scholariq.org/topics/peripheral-artery-disease-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.